• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

战胜困难:影响无关造血干细胞供者提供速度和可用性的因素。

Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.

机构信息

Anthony Nolan, London, UK.

出版信息

Bone Marrow Transplant. 2013 Feb;48(2):210-9. doi: 10.1038/bmt.2012.54. Epub 2012 Apr 9.

DOI:10.1038/bmt.2012.54
PMID:22484322
Abstract

The demand for unrelated haematopoietic cell (HPC) donors has risen threefold over the last decade, and is likely to continue to rise over the next 10 years. The time taken from diagnosis to transplant is recognised to adversely affect patient outcome, and provision of unrelated donors (UDs) has been identified as a key source of delay. Obstacles to provision of UD include: delays in referral to a transplant centre, awaiting sibling typing, lack of matched donors (particularly for those from ethnic minorities and/or with rare HLA phenotypes), low- or intermediate-resolution donor HLA typing, donor attrition from the registries, donor ineligibility on grounds of health and difficulties encountered transporting HPC across international borders. There are now over 18 million volunteer donors in registries worldwide, and efficiency has improved, at least in part, because of a switch from paper to electronic searches. As a result, the average time from search request to transplant is estimated to be less than half of what it was two decades ago. Furthermore, registries have developed a number of strategies designed to minimise delays and, ultimately, improve patient outcomes. These include: optimisation of donor numbers and ethnic mix through focused and selective recruitment; high-resolution typing at donor recruitment; cord blood banking with aggressive recruitment in ethnic minorities; early identification of those unlikely to find a match so alternative transplant options may be pursued in a timely manner, through use of HLA-based predictive algorithms; reduction of donor attrition; centralised, registry-based, donor identification services; and provision of a back-up donor.

摘要

在过去十年中,对无关造血细胞 (HPC) 供体的需求增加了两倍,并且在未来十年中可能会继续增加。从诊断到移植的时间被认为会对患者的预后产生不利影响,并且已经确定提供无关供体 (UD) 是延迟的关键来源。提供 UD 的障碍包括:向移植中心转介延迟、等待兄弟姐妹配型、缺乏匹配的供体(特别是对于少数民族和/或具有罕见 HLA 表型的人)、低分辨率或中分辨率供体 HLA 分型、供体从注册中心流失、由于健康原因供体不合格以及在跨国界运输 HPC 时遇到的困难。目前,全球有超过 1800 万志愿者在注册中心登记,效率有所提高,至少部分原因是从纸质搜索转向电子搜索。因此,从搜索请求到移植的平均时间估计不到 20 年前的一半。此外,注册中心已经制定了许多旨在尽量减少延迟并最终改善患者预后的策略。这些策略包括:通过有针对性和选择性的招募来优化供体数量和种族构成;在招募时进行高分辨率分型;在少数民族中积极招募脐带血库;通过使用基于 HLA 的预测算法,早期识别那些不太可能找到匹配的人,以便及时采用替代移植选择;减少供体流失;集中、基于注册中心的供体识别服务;以及提供后备供体。

相似文献

1
Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision.战胜困难:影响无关造血干细胞供者提供速度和可用性的因素。
Bone Marrow Transplant. 2013 Feb;48(2):210-9. doi: 10.1038/bmt.2012.54. Epub 2012 Apr 9.
2
How to select the best available related or unrelated donor of hematopoietic stem cells?如何选择最佳的造血干细胞相关或无关供体?
Haematologica. 2016 Jun;101(6):680-7. doi: 10.3324/haematol.2015.141119. Epub 2016 May 31.
3
Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.18-40 岁、无 HLA 完全相合同胞供者且免疫抑制治疗失败的成人再生障碍性贫血患者的无关供者搜索和无关供者移植。
Bone Marrow Transplant. 2013 Feb;48(2):198-200. doi: 10.1038/bmt.2012.233. Epub 2012 Nov 26.
4
Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).杜塞尔多夫大学医院同种异体造血干细胞移植的供体选择过程(1997 - 1998年)
Klin Padiatr. 1999 Jul-Aug;211(4):218-23. doi: 10.1055/s-2008-1043792.
5
Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.非血缘供者骨髓移植的现状。国际非血缘骨髓检索与移植(IMUST)研究。
Clin Transpl. 1992:91-107.
6
Trends and challenges in searching for HLA-matched unrelated donors in Israel.在以色列寻找 HLA 匹配的无关供体的趋势和挑战。
Hum Immunol. 2013 Aug;74(8):942-5. doi: 10.1016/j.humimm.2013.04.012. Epub 2013 Apr 22.
7
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.成人高危急性白血病患者替代来源造血干细胞移植
Blood Cells Mol Dis. 2004 Nov-Dec;33(3):294-302. doi: 10.1016/j.bcmd.2004.08.021.
8
[Economic evaluation of the organization of a registry of haematopoietic stem cell donors].[造血干细胞捐献者登记组织的经济评估]
Rev Epidemiol Sante Publique. 2007 Aug;55(4):275-84. doi: 10.1016/j.respe.2007.04.002.
9
Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.血红蛋白病造血干细胞移植无关供者的可及性
Bone Marrow Transplant. 2003 Apr;31(7):547-50. doi: 10.1038/sj.bmt.1703887.
10
Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO).无关供者骨髓移植:意大利骨髓移植协作组(GITMO)经验的最新进展
Haematologica. 2001 May;86(5):451-6.

引用本文的文献

1
Donation-related decision-making among young adult Black and Hispanic members of a hematopoietic stem cell donor registry: A qualitative study.造血干细胞捐献登记系统中年轻成年黑人和西班牙裔成员与捐献相关的决策制定:一项定性研究。
SSM Qual Res Health. 2025 Jun;7. doi: 10.1016/j.ssmqr.2025.100545. Epub 2025 Mar 14.
2
An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement.优化的搜索预后工具,预测 8/8 HLA 等位基因匹配的无关供者采集。
Transplant Cell Ther. 2023 May;29(5):312.e1-312.e5. doi: 10.1016/j.jtct.2023.02.016. Epub 2023 Feb 21.
3
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
成人急性髓系白血病患者接受异基因移植时间差异的分析。
Blood Adv. 2023 Aug 8;7(15):3824-3833. doi: 10.1182/bloodadvances.2022008572.
4
Haploidentical Hematopoietic Stem Cell Transplantation Followed by 'Post-Cyclophosphamide': The Future of Allogeneic Stem Cell Transplant.单倍体相合造血干细胞移植联合“环磷酰胺后处理”:异基因干细胞移植的未来
Clin Hematol Int. 2020 Apr 19;2(2):49-58. doi: 10.2991/chi.d.200405.001. eCollection 2020 Jun.
5
Modern Medical Miracle: Matched Unrelated Donor Hematopoietic Stem Cell Transplant After Aplastic Anemia.现代医学奇迹:再生障碍性贫血后非血缘造血干细胞移植
Cureus. 2021 Feb 1;13(2):e13050. doi: 10.7759/cureus.13050.
6
Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.在美国国家登记处搜索激活后进行异基因造血细胞移植的可能性:患者年龄、疾病和搜索预后的影响。
Transplant Cell Ther. 2021 Feb;27(2):184.e1-184.e13. doi: 10.1016/j.bbmt.2020.10.004. Epub 2020 Oct 10.
7
[Clinical research of HLA-haploidentical peripheral hematopoietic stem cell transplantation following reduced intensity conditioning regimen with hematological malignancy patients over 50 years old].[减低预处理强度的HLA单倍型相合外周血造血干细胞移植治疗50岁以上血液系统恶性肿瘤患者的临床研究]
Zhonghua Xue Ye Xue Za Zhi. 2019 Aug 14;40(8):667-672. doi: 10.3760/cma.j.issn.0253-2727.2019.08.008.
8
Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.移植后环磷酰胺促进 HLA 单倍体造血细胞移植:机制与结果。
Semin Hematol. 2019 Jul;56(3):183-189. doi: 10.1053/j.seminhematol.2018.09.002. Epub 2018 Sep 20.
9
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.未经调控的单倍体相合与同胞相合供者造血干细胞移植治疗伴有中高危细胞遗传学异常的急性髓系白血病患者在首次完全缓解后的结果:来自欧洲血液和骨髓移植学会急性白血病工作组的一项研究。
Haematologica. 2018 Aug;103(8):1317-1328. doi: 10.3324/haematol.2018.189258. Epub 2018 May 10.
10
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.无关供者选择评分的开发可预测 HCT 后的生存:供者年龄最重要。
Biol Blood Marrow Transplant. 2018 May;24(5):1049-1056. doi: 10.1016/j.bbmt.2018.02.006. Epub 2018 Feb 14.